特例承認 against Huaiza K.K.
ファイザー株式会社 (医薬品医療機器等法)
医薬品医療機器等法Ministry of Health, Labour and WelfareJanuary 21, 2022
Action summary
- Company
- Huaiza K.K.RomanizedOriginal: ファイザー株式会社Corporate Number: 5011001126167
- Governing law
- 医薬品医療機器等法医薬品医療機器等法
- Action type
- 特例承認特例承認
- Action date
- January 21, 2022
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
Violation
Machine-translated summary — verify against original
A special approval was granted under Article 14-3 of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices concerning a partial change to the manufacturing and marketing approval for the COVID-19 vaccine.
Show original Japanese text
新型コロナウイルス感染症に係るワクチンの製造販売承認事項の一部変更について、医薬品医療機器等法第14条の３に基づく特例承認を行いました。
Source
Original Ministry of Health, Labour and Welfare announcement (in Japanese)The original Japanese disclosure is the authoritative record.
Watch this company
Get an email when Huaiza K.K. has new enforcement actions or registry changes (representative, address, business status). Sign-in is via a one-time email link — no password.
Language
日本語版を見る (Japanese)Company info
- English name
- Huaiza K.K. Romanized
- Japanese name
- ファイザー株式会社
- Corporate Number
- 5011001126167
- Registered address
- 東京都渋谷区代々木３丁目２２番７号
About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.